End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.16 CNY | +0.96% | 0.00% | -5.67% |
04-25 | Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-11 | Harbin Pharma to Upgrade Subsidiary's Production Base for 50 Million Yuan | MT |
Business Summary
Number of employees: 9,853
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Wholesale Medical
39.8
%
| 5,930 | 42.9 % | 6,150 | 39.8 % | +3.71% |
Nutritional Supplements
18.5
%
| 2,034 | 14.7 % | 2,865 | 18.5 % | +40.84% |
Wholesale Commercial
16.2
%
| 2,135 | 15.5 % | 2,501 | 16.2 % | +17.14% |
Retail
10.4
%
| 1,450 | 10.5 % | 1,601 | 10.4 % | +10.35% |
Anti-virus and Anti-infection
6.6
%
| 886 | 6.4 % | 1,016 | 6.6 % | +14.67% |
Cold Medicine
3.5
%
| 584 | 4.2 % | 536 | 3.5 % | -8.12% |
Digestive System
1.7
%
| 300 | 2.2 % | 256 | 1.7 % | -14.44% |
Cardiovascular
1.4
%
| 290 | 2.1 % | 222 | 1.4 % | -23.69% |
Inter-Segment Offset
-1.4
%
| -292 | -2.1 % | -219 | -1.4 % | -24.85% |
Anti-tumor
1.4
%
| 157 | 1.1 % | 214 | 1.4 % | +36.46% |
Industrial - Others
1.0
%
| 198 | 1.4 % | 161 | 1.0 % | -18.78% |
Commercial - Others
0.6
%
| 82 | 0.6 % | 97 | 0.6 % | +18.69% |
Other Business
0.4
%
| 54 | 0.4 % | 56 | 0.4 % | +4.82% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
93.1
%
| 13,456 | 97.4 % | 14,388 | 93.1 % | +6.93% |
Overseas
6.9
%
| 353 | 2.6 % | 1,069 | 6.9 % | +202.80% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Bo Liu
DFI | Director of Finance/CFO | 61 | 08-09-25 |
Kun Yu Ma
IRC | Investor Relations Contact | 43 | 14-04-30 |
Xiao Dong Meng
SEC | Corporate Secretary | 52 | 04-12-23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Xiao Dong Meng
SEC | Corporate Secretary | 52 | 04-12-23 |
Ai Dong Lou
BRD | Director/Board Member | 58 | 21-01-07 |
Bo Liu
DFI | Director of Finance/CFO | 61 | 08-09-25 |
Zhao Hua Li
BRD | Director/Board Member | 58 | 21-01-07 |
Xiao Ping Hu
CHM | Chairman | 54 | 22-06-26 |
Ying Lei
BRD | Director/Board Member | 67 | 12-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,521,278,976 | 1,221,919,310 ( 48.46 %) | 2,769,100 ( 0.1098 %) | 48.46 % |
Company contact information
Harbin Pharmaceutical Group Co., Ltd.
7 Qunli Avenue Daoli District
150070, Harbin
+86 45 1518 70240
http://www.hayao.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-5.67% | 1.09B | |
+29.56% | 682B | |
+30.35% | 586B | |
-3.80% | 364B | |
+17.48% | 327B | |
+3.31% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+7.24% | 165B |
- Stock Market
- Equities
- 600664 Stock
- Company Harbin Pharmaceutical Group Co., Ltd.